<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8710219</journal-id><journal-id journal-id-type="pubmed-jr-id">1493</journal-id><journal-id journal-id-type="nlm-ta">AIDS</journal-id><journal-id journal-id-type="iso-abbrev">AIDS</journal-id><journal-title-group><journal-title>AIDS (London, England)</journal-title></journal-title-group><issn pub-type="ppub">0269-9370</issn><issn pub-type="epub">1473-5571</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40162985</article-id><article-id pub-id-type="pmc">12202163</article-id><article-id pub-id-type="doi">10.1097/QAD.0000000000004193</article-id><article-id pub-id-type="manuscript">HHSPA2076763</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Systematic Review of Infodemiology Studies Using Artificial Intelligence: Social Media Posts on HIV Pre-exposure Prophylaxis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kamitani</surname><given-names>Emiko</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>DeLuca</surname><given-names>Julia B.</given-names></name><degrees>MLIS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Mizuno</surname><given-names>Yuko</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1.</label>Division of HIV Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States 30329-4027</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author Contributions:</p><p id="P2">All authors on this article meet the four criteria for authorship as identified by the International Committee of Medical Journal Editors (ICMJE); all authors have contributed to the conception and design of the study, drafted or have been involved in revising this manuscript, reviewed the final version of this manuscript before submission, and agree to be accountable for all aspects of the work. Specifically, using the CRediT taxonomy, the contribution of each author is as follows: Conceptualization: E. Kamitani, Y. Mizuno, and J.B. DeLuca; Original Draft: E. Kamitani; Revision of manuscript: E. Kamitani; Y. Mizuno, and J.B. DeLuca.</p></fn><corresp id="CR1"><label>*</label>Corresponding author: Emiko Kamitani, <email>ekamitani@cdc.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>7</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>7</month><year>2025</year></pub-date><volume>39</volume><issue>9</issue><fpage>1254</fpage><lpage>1261</lpage><abstract id="ABS1"><sec id="S1"><title>Objectives.</title><p id="P3">To explore how artificial intelligence (AI) can enhance infodemiology, which distributes and scans information in the electronic medium, to process social media posts for HIV pre-exposure prophylaxis (PrEP).</p></sec><sec id="S2"><title>Design:</title><p id="P4">Systematic Review</p></sec><sec id="S3"><title>Methods.</title><p id="P5">We searched in the U.S. Centers for Disease Control and Prevention&#x02019;s Prevention Research Synthesis database through June 2024 (PROSPERO: CRD42023458870). We included infodemiology studies published in English and reported using AI to process social media posts on PrEP. Two reviewers independently screened citations, extracted data, and conducted a risk of bias assessment using the Joanna Briggs Institute Critical Appraisal Checklist for Prevalence Studies. Findings are narratively summarized.</p></sec><sec id="S4"><title>Results.</title><p id="P6">Of the 135 citations screened, eight infodemiology studies were identified, analyzing over 58.9 million posts. Infodemiology studies found the PrEP topics commonly discussed in communities (e.g., barriers of uptake), rumors that may raise public health concerns (e.g., PrEP is a prevention method against COVID-19 infection), geographic locations where concerns regarding risk of acquiring HIV were raised (e.g., most HIV-related posts were from the 10 states with the highest numbers of new HIV diagnoses), and predicted HIV trends (e.g., HIV-related tweets were negatively correlated with the county-level HIV incidence rate in the following year).</p></sec><sec id="S5"><title>Conclusions.</title><p id="P7">Despite the limitations of this review including a small number of studies reviewed, our review suggests social media posts may provide information on real-time PrEP-related concerns, and AI can accelerate and enhance the processing of mass data to identify the information that communities need and the areas/locations that may need HIV prevention intervention.</p></sec></abstract><kwd-group><kwd>HIV</kwd><kwd>pre-exposure prophylaxis</kwd><kwd>artificial intelligence</kwd><kwd>infodemiology</kwd><kwd>social media</kwd><kwd>machine leaning</kwd></kwd-group></article-meta></front><body><p id="P8">Social media has been one of the most popular sources for retrieving information, and its use is constantly expanding [<xref rid="R1" ref-type="bibr">1</xref>]. In 2023, an estimated 4.9 billion people around the world used social media to share information and engage with news content [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>]. Social media platforms are well used by all race/ethnicity groups and sexual orientations, and users frequently share and openly engage in discussions about their health practices, including those related to HIV [<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref>].</p><p id="P9">Studies that report findings from infodemiology (the distribution of health information in electronic media to inform public health and public policy) have been on the rise [<xref rid="R8" ref-type="bibr">8</xref>]. Infodemiology allows us to obtain real-time, user-generated data from multiple social media platforms (e.g., a microblogging site [X], a news aggregation and discussion site [Reddit], photo and video sharing platform [Instagram]) [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>]. These data are difficult to collect with traditional, time-consuming survey methods [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>]. Infodemiology is especially advantageous for getting behavioral responses (e.g., acceptance of vaccinations, prevention and control practice) to health-related issues [<xref rid="R11" ref-type="bibr">11</xref>] and information on sensitive topics, such as HIV and pre-exposure prophylaxis (PrEP) knowledge and behaviors, especially among disproportionately affected groups [<xref rid="R12" ref-type="bibr">12</xref>].</p><p id="P10">Social media content expands every second. Scanning and analyzing big data, such as social media posts, are time-consuming and require significant efforts in filtering and removing unwanted information [<xref rid="R13" ref-type="bibr">13</xref>]. Artificial intelligence (AI), such as machine learning (ML) or deep learning (DL), may help process social media posts [<xref rid="R14" ref-type="bibr">14</xref>]. AI is defined as a multidisciplinary field that focuses on developing intelligent systems capable of performing tasks that typically require human intelligence [<xref rid="R15" ref-type="bibr">15</xref>]. ML enables computers to learn from historical data and improve their performance without explicit programming [<xref rid="R16" ref-type="bibr">16</xref>], while DL simulates the complex decision-making processes of the human brain through multilayered neural networks [<xref rid="R17" ref-type="bibr">17</xref>]. Because of its real-world applications and ability to mimic human decision-making and judgment, AI has rapidly been adopted in medical care, especially during the COVID-19 pandemic to obtain or provide COVID&#x02013;19-related information [<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref>]. This study is the first systematic review, to our knowledge, that describes infodemiology studies that used AI to process mass social media data to understand what communities are saying about HIV PrEP, to identify the advantages and disadvantages of using AI for this purpose, and to determine the next steps.</p><sec id="S6"><title>METHODS</title><p id="P11">The study protocol for the parent review [<xref rid="R20" ref-type="bibr">20</xref>] was registered in PROSPERO (CRD42023458870) [<xref rid="R21" ref-type="bibr">21</xref>]. Our report followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRSIMA) Statement [<xref rid="R22" ref-type="bibr">22</xref>].</p><sec id="S7"><title>Search</title><p id="P12">A search was conducted in CDC&#x02019;s Prevention Research Synthesis (PRS) Project database that had amassed more than 130,000 HIV prevention citations by the end of March 2025. Details of search strategies were published elsewhere [<xref rid="R20" ref-type="bibr">20</xref>]. For this review, a PRS Project team librarian searched the PRS database in August 2023, with a second query conducted in March 2024, for literature published from 2012 to the present. Two components were used in the search. The first component looked at AI with phrases centered on ML and natural language. The second component focused on pre-exposure prophylaxis and PrEP. The search query looked specifically at the title, abstract, and indexing terms for citations focused on PrEP and AI. We also searched for any newly published literature in PubMed, Scopus, and Google Scholar by using the same search terms (June 2024). See the <xref rid="SD1" ref-type="supplementary-material">Appendix</xref> for full PrEP annual searches, PRS database queries, and supplementary searches for this review.</p></sec><sec id="S8"><title>Inclusion/Exclusion Criteria</title><p id="P13">Studies published in English and reported using AI, such as ML or natural language processing (NLP), to assess social media posts related to PrEP were included. We excluded studies that used AI to assess HIV information in general and did not focus on PrEP.</p></sec><sec id="S9"><title>Screening and Data Abstraction</title><p id="P14">A two-step approach was applied to select studies. First, two reviewers independently screened the citations by title and abstract. Second, two reviewers independently reviewed the full text of included citations to confirm study eligibility. Disagreements were resolved through discussion. If the two reviewers failed to reach an agreement, a third reviewer resolved the discrepancy. Reviewers were trained, and all screening forms were pilot-tested and revised as necessary. Identified citations were exported to DistilleSR (a systematic review software, Evidence Partners, Ottawa, Canada) for data management to screen and identify eligible studies. For all eligible studies, two reviewers extracted data on population characteristics and AI program-related information and outcomes with a standard data abstraction form.</p></sec><sec id="S10"><title>Quality Assessment/Data Synthesis</title><p id="P15">Study quality assessment of included studies was conducted by using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Prevalence Studies [<xref rid="R23" ref-type="bibr">23</xref>, <xref rid="R24" ref-type="bibr">24</xref>]. The JBI checklist consisted of 9 questions with &#x0201c;yes&#x0201d; (1 point), &#x0201c;no&#x0201d; (0 points), &#x0201c;unclear&#x0201d; (0 points), or not applicable&#x0201d; (0 points). A total score of nine was possible, with four or less being considered as &#x0201c;high,&#x0201d; five or six being considered as &#x0201c;moderate,&#x0201d; and seven to nine considered as &#x0201c;low&#x0201d; [<xref rid="R25" ref-type="bibr">25</xref>&#x02013;<xref rid="R27" ref-type="bibr">27</xref>]. We narratively synthesized the characteristics and findings of the included studies.</p></sec></sec><sec id="S11"><title>RESULTS</title><p id="P16">Of the 142 identified citations, 53 were duplications and 32 were excluded by title screening (<xref rid="F1" ref-type="fig">Figure 1</xref>). Of the remaining 57 citations, 49 were excluded by full-report screening because they were modeling studies (n=21), interventional studies (n=13), non-AI studies (n=8), reviews (n=6), or non-PrEP&#x02013;relevant studies (n=1). The remaining 8 studies were eligible for this review.</p><p id="P17">The study years included were from 2010 through 2022 (<xref rid="T1" ref-type="table">Table 1</xref>). Because social media posts could not be validated and may not be reliable, all studies scored low on our study quality assessment for measurement, classification, and other biases. Additionally, because social media posts were voluntary and may not represent the voices of those who did not use social media, the study&#x02019;s validity was diminished; thus, all studies had moderate risk of bias.</p><p id="P18">Studies used ML in various social media platforms to identify HIV or PrEP-related social media posts (e.g., text, still images, video footage) with the hashtag #HIV or #PrEP on Instagram [<xref rid="R28" ref-type="bibr">28</xref>&#x02013;<xref rid="R31" ref-type="bibr">31</xref>], Reddit [<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R31" ref-type="bibr">31</xref>], Tumblr [<xref rid="R31" ref-type="bibr">31</xref>], X (formerly Twitter) [<xref rid="R30" ref-type="bibr">30</xref>&#x02013;<xref rid="R35" ref-type="bibr">35</xref>], or YouTube [<xref rid="R31" ref-type="bibr">31</xref>]. Three studies used NLP [<xref rid="R29" ref-type="bibr">29</xref>, <xref rid="R33" ref-type="bibr">33</xref>, <xref rid="R34" ref-type="bibr">34</xref>], which mimicked human decision-making, while one study [<xref rid="R28" ref-type="bibr">28</xref>] used convolutional neural networks (CNNs) for analyzing visual imagery.</p><p id="P19">The total number of social media posts screened by the included studies was more than 58.9 million. The highest number screened for one study was by Adrover [<xref rid="R36" ref-type="bibr">36</xref>], who purchased from an official X data reseller almost 40 million tweets that represented the full and unbiased stream of data posted between September 2010 and August 2013. The elements in social media posts that AI analyzed were categorized as either language content (e.g., tweets, texts) or visual content (e.g., still images, video footage).</p><sec id="S12"><title>Language Content</title><p id="P20">The included infodemiology studies scanned more than 55.8 million tweets and texts with ML or NLP and identified 15,217 relevant social media posts (0.03%). The tweets were posted mainly on X between September 2010 and December 2021 and represented a variety of real-time conversations in communities.</p><p id="P21">Erdengaslieng [<xref rid="R35" ref-type="bibr">35</xref>] randomly selected 1,200 of 3,700 PrEP-related tweets posted between January 2018 - December 2021 to understand the perceptions, awareness, and barriers to using PrEP. They reported that one of the major PrEP-related tweet topics advocated for better access to PrEP with insurance coverage and stated that pricing was the major reason for not using PrEP [<xref rid="R35" ref-type="bibr">35</xref>].</p><p id="P22">Adrover [<xref rid="R36" ref-type="bibr">36</xref>] screened X around July 16, 2012, to identify tweets discussing the adverse effects of antiretroviral therapy and associated sentiments around that date when the U.S. Food and Drug Administration (FDA) approved Truvada for PrEP. Out of approximately 40 million tweets, they identified 1,642 tweets and 512 unique users who described personal experiences with HIV drug treatment between September 2010 to August 2013 [<xref rid="R37" ref-type="bibr">37</xref>]. In the summer of 2012, around the time of the FDA approval, they observed a peak in tweeting about Truvada with increased media attention. The tweets included a significant number of negative posts, such as adverse effects of the medication (e.g., renal toxicity, nausea, vomiting) [<xref rid="R36" ref-type="bibr">36</xref>]. The tweets represented novel events, such as the availability of PrEP to prevent HIV infection and the adverse effects or negative sentiments, that may have been widely discussed in communities.</p><p id="P23">Xu used social media posts to explore the disruptions in PrEP care [<xref rid="R31" ref-type="bibr">31</xref>] and barriers to PrEP uptake during the COVID-19 pandemic [<xref rid="R30" ref-type="bibr">30</xref>]. The authors screened, from October 2020 to December 2020, 522,430 posts on X, YouTube, Tumblr, Instagram, and Reddit. Terms linked to PrEP and HIV were examined to explore PrEP experiences, attitudes, and barriers among racial/ethnic minorities and sexual minorities [<xref rid="R31" ref-type="bibr">31</xref>]. Based on 785 identified posts, the impact of COVID-19 included access issues due to limited PrEP care services and lack of insurance coverage, referral, and transportation services [<xref rid="R31" ref-type="bibr">31</xref>]. The authors also scanned 267,689 posts from March 13, 2020 to December 11, 2020, a time of emerging concern for COVID-19 [<xref rid="R30" ref-type="bibr">30</xref>]. They identified 317 posts on X, Reddit, and Instagram discussing PrEP and COVID-19. The major themes identified were concerns that resources were being taken away from PrEP due to COVID-19 and that the pandemic contributed to disruption in PrEP uptake due to the inaccessibility of clinics. False information and myths regarding PrEP uptake included that PrEP could be used as a prevention method or precaution against COVID-19 infections [<xref rid="R30" ref-type="bibr">30</xref>]. Authors also found reduced self-reported sexual behavior and perceived lower HIV risk due to social distancing. This led to self-reported termination of PrEP and other HIV prevention methods [<xref rid="R30" ref-type="bibr">30</xref>].</p><p id="P24">Two studies [<xref rid="R33" ref-type="bibr">33</xref>, <xref rid="R34" ref-type="bibr">34</xref>] used geolocation of HIV-related tweets and assessed the association with incidence rates of HIV infection. Klein [<xref rid="R34" ref-type="bibr">34</xref>] scanned over 3 million tweets containing keywords of gay, bisexual, and other men who have sex with men (collectively referred to as MSM) posted between September 2020 and January 2021 and identified 8,756 unique users with U.S. state-level geolocations and their ages. The authors found that most HIV-related posts (the residence of MSM users) were from the 10 states with the highest numbers of new HIV diagnoses in the United States. Moreover, over two-thirds (68%) of users with county-level geolocations were in counties or states considered priority jurisdictions by the Ending the HIV Epidemic in the U.S. initiative. The age distribution reflected that of persons who received a new diagnosis of HIV in the United States, with the 25&#x02013;34 years age group being the most common, followed by the 13&#x02013;24 years age group [<xref rid="R34" ref-type="bibr">34</xref>].</p><p id="P25">The second study by Stevens [<xref rid="R33" ref-type="bibr">33</xref>] explored associations between the number of geolocated HIV-related tweets and the future incidence rates of HIV infection. The authors examined how X activities among young men (aged 13&#x02013;24 years) were related to the incidence of HIV infection in the United States. Reviewing 15.1 million tweets (2,517 were relevant) posted during all of 2016 (January 1&#x02013;December 31, 2016), the study found that HIV-specific tweets were more likely to appear in counties where HIV incidence rates were high. Furthermore, geolocated HIV tweets were negatively associated with the county-level HIV incidence rate in the following year; for each additional 100 HIV-specific tweets per person in a particular county, there was a 3% reduction in the HIV incidence rate in the following year [<xref rid="R33" ref-type="bibr">33</xref>].</p></sec><sec id="S13"><title>Visual Content</title><p id="P26">Included infodemiology studies scanned 65,999 image-based posts with CNN or NLP and identified 36,802 relevant social media posts (56%). All of these were posted on Instagram from January 2017 through July 2018.</p><p id="P27">Nobles screened the social media posts to explore the demographic characteristics of human faces posted with the hashtag #HIV [<xref rid="R28" ref-type="bibr">28</xref>] and concepts of these images [<xref rid="R29" ref-type="bibr">29</xref>]. For the former study, the authors screened 26,766 Instagram posts to explore HIV risk perception and communication in public health and found 10,036 with detectable human faces [<xref rid="R28" ref-type="bibr">28</xref>]. Social media posts with the hashtag #HIV on Instagram often feature faces of individuals from groups that tend to have a lower prevalence of HIV infections, such as older adults, women, and white persons. This discrepancy might lead Instagram users to potentially misjudge their HIV risk [<xref rid="R28" ref-type="bibr">28</xref>]. For the latter study, the authors examined 39,233 posts and identified 26,766 that were relevant. They found that the visual content of posts with the hashtag #HIV primarily focused on presenting infographics about clinical interventions (like PrEP) presented images of persons aimed at reducing the stigma of sexual minorities and persons with HIV, and shared their anonymized HIV test results [<xref rid="R29" ref-type="bibr">29</xref>].</p></sec></sec><sec id="S14"><title>DISCUSSION</title><p id="P28">This systematic review identified 8 infodemiology studies that used AI to screen more than 58.9 million social media posts. Analyzing language elements (e.g., tweets, texts) in social media enabled us to analyze PrEP-related experiences or concerns (e.g., barriers to uptake [<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R35" ref-type="bibr">35</xref>], adverse effects of PrEP [<xref rid="R36" ref-type="bibr">36</xref>]), and rumors (e.g., PrEP can prevent COVID-19 infection [<xref rid="R30" ref-type="bibr">30</xref>]). Analysis also allowed for the geolocation of MSM who may be PrEP candidates [<xref rid="R34" ref-type="bibr">34</xref>] and to predict trends of HIV incidence [<xref rid="R33" ref-type="bibr">33</xref>]. Meanwhile, analyzing visual elements (e.g., still images, video footage) on video platforms (e.g., Instagram) revealed demographic profiles of pictures of human faces posted [<xref rid="R28" ref-type="bibr">28</xref>] and images of #HIV posts [<xref rid="R29" ref-type="bibr">29</xref>]. Here, we discuss how AI can enhance infodemiology to process social media posts, the advantages and disadvantages of using AI in the field, and future uses of AI for analysis.</p><p id="P29">First, infodemiology studies using AI can help gather mass data. This includes real-time, health-related information and how people consume such information (e.g., adverse effects of medications [<xref rid="R36" ref-type="bibr">36</xref>] or accessibility of care during public health emergencies [<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R31" ref-type="bibr">31</xref>]), from a wide variety of communities; specifically from those who may not be included in traditional surveys. One of the biggest questions is the reliability and accuracy of capturing the actual communities&#x02019; experiences and conversations.</p><p id="P30">The Infodemiology studies in this review found that the reasons for changes in PrEP use during the COVID-19 pandemic were the inaccessibility of PrEP care [<xref rid="R31" ref-type="bibr">31</xref>] and reduced sexual behaviors [<xref rid="R30" ref-type="bibr">30</xref>]. These were the 2 most common impacts of COVID-19 found by a recent systematic review examining the influences of the pandemic on PrEP care from 46 studies [<xref rid="R38" ref-type="bibr">38</xref>]. Additionally, renal toxicity, nausea, and vomiting reported on X as experiences of the communities [<xref rid="R36" ref-type="bibr">36</xref>] are well-recognized potential side effects of PrEP [<xref rid="R39" ref-type="bibr">39</xref>]. These findings indicated that scanning social media posts with AI can capture information typically collected by using traditional time-consuming and labor-intensive surveys, but with the advantage of collecting mass data quickly in a timely manner.</p><p id="P31">Second, social media helps spread public health information quickly and widely. Relative to traditional media (e.g., newspapers, TV, radio broadcasts), social media accelerates the recirculating of information [<xref rid="R36" ref-type="bibr">36</xref>]. As an example, tweeting about the first antiretroviral treatment approved for PrEP (i.e., Truvada) hit a peak when the FDA approval spurred coverage by the traditional media [<xref rid="R36" ref-type="bibr">36</xref>]. 512 unique users who tweeted about their HIV experiences on X had an average of 2,300 followers between 2010-2013 [<xref rid="R36" ref-type="bibr">36</xref>]. This suggests that a post by one person can spread broadly and influence thousands of followers and communities.</p><p id="P32">Meanwhile, one of the major PrEP-related tweet topics was to advocate better access, stating that insurance coverage and pricing were the major concerns in accessing care and using PrEP [<xref rid="R35" ref-type="bibr">35</xref>]. As a matter of fact, financial support, including changes in medication options (e.g., availability of generic drugs), Medicaid expansion, insurance coverage policies and regulations (e.g., Affordable Care Act or ACA), and PrEP assistance programs from manufacturers, are available [<xref rid="R40" ref-type="bibr">40</xref>]. A significant barrier may be low PrEP awareness, including a lack of information on the availability of PrEP financial support. Thus, when we introduce or promote preventive or public health strategies, we can take advantage of the influential factors of social networks and social media posts to promote awareness of the strategies [<xref rid="R36" ref-type="bibr">36</xref>].</p><p id="P33">On the other hand, information posts on social media may not always be appropriate or accurate. Negative sentiment may increase and influence communities to raise concerns [<xref rid="R36" ref-type="bibr">36</xref>]. For example, tweets associating undesirable medical experiences, such as adverse effects of medications, may negatively impact persons interested in the medications. False information can also be widely shared. During the COVID-19 pandemic, the rumor that PrEP can be used as a prevention method or precaution against COVID-19 infection was widely spread on X [<xref rid="R30" ref-type="bibr">30</xref>]. Evidence that PrEP can prevent COVID-19 infection, or lead to a less severe course of COVID-19 disease, has not been presented or verified [<xref rid="R41" ref-type="bibr">41</xref>].</p><p id="P34">Our current analyses do not explicitly differentiate between the sources of social media posts. However, distinguishing between unsolicited or unregulated posts and those posted by authoritative sources (e.g., government agencies, community organizations) or professionals and experts could provide deeper insights into the sources of information shared on social media. Future studies in this area could explore this differentiation in greater detail to better understand the impact of different sources on public perceptions and behaviors.</p><p id="P35">Social media can serve as both a powerful tool for promoting awareness and a platform that may contribute to the spread of misinformation. By targeting key influencers, addressing misinformation, or providing additional information to communities on social media platforms, we can enhance PrEP awareness and uptake.</p><p id="P36">Next, geolocated social media posts can identify populations with concerns and where those issues are across the country. Our review found that HIV-related tweets were more likely to be posted from the counties that had high HIV incidence rates or the priority jurisdictions of the Ending the HIV Epidemic in the U.S. initiative [<xref rid="R33" ref-type="bibr">33</xref>, <xref rid="R34" ref-type="bibr">34</xref>]. Meanwhile, the HIV-related tweets were negatively associated with the county-level HIV incidence rate in the following year [<xref rid="R33" ref-type="bibr">33</xref>]. These findings could suggest that higher numbers of HIV-related tweets may be indicators of increased risk awareness, support, and community involvement [<xref rid="R33" ref-type="bibr">33</xref>]. Additionally, faces appearing in social media posts with the #HIV hashtag are more likely to belong to individuals who have a lower risk of HIV infection, especially older persons, women, and White persons. This could suggest that HIV-related social media posts may not resonate with persons at high risk for HIV and they might underestimate their own risk [<xref rid="R28" ref-type="bibr">28</xref>].</p><p id="P37">Finally, noise problems in ML could be tricky and impact the performance of scanning and analyzing social media posts. &#x0201c;Noise&#x0201d; means tweets about unrelated topics. By dropping the search terms that could be noise [<xref rid="R36" ref-type="bibr">36</xref>], analysis problems can be reduced but the ability to identify relevant data may also be reduced. The strategies of noise reduction, such as data cleaning, algorithm selection, and validation, should be well planned and executed. Beyond the use of AI, researchers still have to go through several validation steps, crowdsourcing, and human interventions to declare the validity of filters [<xref rid="R32" ref-type="bibr">32</xref>]. Additionally, further refining AI algorithms to identify relevant, high-quality, and influential social media posts related to PrEP is necessary. The integration of such factors as context, source credibility, and legitimacy into AI models is crucial to ensure that analyses capture not only the volume of posts but also evaluate their quality and influence.</p><p id="P38">One of the review limitations was the limited number of studies identified and reviewed. This is likely due to the evolving nature of research in this field, as well as the relatively novel application of AI in PrEP and infodemiology studies. Some of the evidence discussed in this review was concluded from single studies rather than from a synthesis of multiple studies. It is important to avoid making overly broad conclusions based on the limited number of studies. A synthesis of evidence across multiple studies is needed to draw more definitive conclusions and guide policy and practice effectively. Additionally, the variability in platforms used, study years, and data collection methods presented challenges in generalizing the findings across studies. Our included studies did not provide detailed information on several aspects, such as content type, engagement metrics, tone, and target audiences, which are crucial for understanding the reach and impact of these posts. To strengthen the evidence of PrEP use and behavioral trends, we need additional high-quality studies that explore these research areas in greater depth and consistency.</p><p id="P39">In conclusion, this review found that infodemiology studies provide real-time, public health trends and behaviors. AI, including ML and DL, helps scan mass, real-time, user-generated data on social media platforms quickly and accurately to capture simultaneous public health concerns and the locations/communities of those discussing the concerns. Social media data may serve as a proxy of people&#x02019;s behaviors in communities, and analyzing big data has the potential to provide the information needed to improve patient outcomes and gain new insights into various human behaviors [<xref rid="R42" ref-type="bibr">42</xref>&#x02013;<xref rid="R44" ref-type="bibr">44</xref>]. Our review explored whether AI can be used to identify populations who may face public health concerns and the areas/locations that may need public health interventions the most, as well as messages that the public seeks. However, we cannot ignore the issue of infodemic, which refers to an excessive amount of information, including false information in online or offline settings [<xref rid="R45" ref-type="bibr">45</xref>]. AI may further help identify specific public health topics that are unnecessary in certain locations. We should take advantage of developing technology and use it appropriately and wisely to improve and promote good health for all.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>appendix</label><media xlink:href="NIHMS2076763-supplement-appendix.docx" id="d67e527" position="anchor"/></supplementary-material></sec></body><back><ack id="S15"><p id="P40">The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention. This work was entirely funded by the U.S. Government. All authors are federal government employees and this report is not subject to copyright in the United States.</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p id="P41">Disclosure: There are no conflicts of interest to report or financial disclosures.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="webpage"><collab>Pew Research Center</collab>. <source>Social Media Fact Sheet</source>
<year>2022</year> [updated <date-in-citation>January 11</date-in-citation>. Available from: <ext-link xlink:href="https://www.pewresearch.org/internet/fact-sheet/social-media/" ext-link-type="uri">https://www.pewresearch.org/internet/fact-sheet/social-media/</ext-link>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="webpage"><collab>Pew Research Center</collab>. <source>Social Media Fact Sheet</source>
<year>2024</year> [updated <date-in-citation>January 31, 2024</date-in-citation>. Available from: <ext-link xlink:href="https://www.pewresearch.org/internet/fact-sheet/social-media/" ext-link-type="uri">https://www.pewresearch.org/internet/fact-sheet/social-media/</ext-link>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="webpage"><collab>Forbes</collab>. <source>Top Social Media Statistics and Trends of 2024</source>
<year>2023</year> [updated <date-in-citation>May 18, 2023</date-in-citation>. Available from: <ext-link xlink:href="https://www.forbes.com/advisor/business/social-media-statistics/#source" ext-link-type="uri">https://www.forbes.com/advisor/business/social-media-statistics/#source</ext-link>.</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>M</given-names></name>, <name><surname>Shah</surname><given-names>N</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>WH</given-names></name>, <name><surname>Cuomo</surname><given-names>RE</given-names></name>, <name><surname>Obradovich</surname><given-names>N</given-names></name>, <etal/>
<article-title>Identification and characterization of tweets related to the 2015 Indiana HIV outbreak: A retrospective infoveillance study</article-title>. <source>PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>8</issue>):<fpage>e0235150</fpage>.<pub-id pub-id-type="pmid">32845882</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Taggart</surname><given-names>T</given-names></name>, <name><surname>Grewe</surname><given-names>ME</given-names></name>, <name><surname>Conserve</surname><given-names>DF</given-names></name>, <name><surname>Gliwa</surname><given-names>C</given-names></name>, <name><surname>Roman Isler</surname><given-names>M</given-names></name>. <article-title>Social Media and HIV: A Systematic Review of Uses of Social Media in HIV Communication</article-title>. <source>J Med Internet Res</source>. <year>2015</year>;<volume>17</volume>(<issue>11</issue>):<fpage>e248</fpage>.<pub-id pub-id-type="pmid">26525289</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>van Heerden</surname><given-names>A</given-names></name>, <name><surname>Young</surname><given-names>S</given-names></name>. <article-title>Use of social media big data as a novel HIV surveillance tool in South Africa</article-title>. <source>PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>10</issue>):<fpage>e0239304</fpage>.<pub-id pub-id-type="pmid">33006979</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Kudrati</surname><given-names>SZ</given-names></name>, <name><surname>Hayashi</surname><given-names>K</given-names></name>, <name><surname>Taggart</surname><given-names>T</given-names></name>. <article-title>Social Media &#x00026; PrEP: A Systematic Review of Social Media Campaigns to Increase PrEP Awareness &#x00026; Uptake Among Young Black and Latinx MSM and Women</article-title>. <source>AIDS Behav</source>. <year>2021</year>;<volume>25</volume>(<issue>12</issue>):<fpage>4225</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">33939035</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Klimiuk</surname><given-names>KB</given-names></name>, <name><surname>Balwicki</surname><given-names>&#x00141;W</given-names></name>. <article-title>What is infodemiology? An overview and its role in public health</article-title>. <source>Przegl Epidemiol</source>. <year>2024</year>;<volume>78</volume>(<issue>1</issue>):<fpage>81</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">38904314</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Eysenbach</surname><given-names>G</given-names></name>. <article-title>Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet</article-title>. <source>J Med Internet Res</source>. <year>2009</year>;<volume>11</volume>(<issue>1</issue>):<fpage>e11</fpage>.<pub-id pub-id-type="pmid">19329408</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Eysenbach</surname><given-names>G</given-names></name>. <article-title>Infodemiology: The epidemiology of (mis)information</article-title>. <source>Am J Med</source>. <year>2002</year>;<volume>113</volume>(<issue>9</issue>):<fpage>763</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">12517369</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>. <article-title>Social Media Use for Health Purposes: Systematic Review</article-title>. <source>J Med Internet Res</source>. <year>2021</year>;<volume>23</volume>(<issue>5</issue>):<fpage>e17917</fpage>.<pub-id pub-id-type="pmid">33978589</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Mavragani</surname><given-names>A</given-names></name>, <name><surname>Ochoa</surname><given-names>G</given-names></name>. <article-title>Forecasting AIDS prevalence in the United States using online search traffic data</article-title>. <source>Journal of Big Data</source>. <year>2018</year>;<volume>5</volume>(<issue>1</issue>):<fpage>17</fpage>.</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Bazzaz Abkenar</surname><given-names>S</given-names></name>, <name><surname>Haghi Kashani</surname><given-names>M</given-names></name>, <name><surname>Mahdipour</surname><given-names>E</given-names></name>, <name><surname>Jameii</surname><given-names>SM</given-names></name>. <article-title>Big data analytics meets social media: A systematic review of techniques, open issues, and future directions</article-title>. <source>Telemat Inform</source>. <year>2021</year>;<volume>57</volume>:<fpage>101517</fpage>.<pub-id pub-id-type="pmid">34887614</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Saheb</surname><given-names>T</given-names></name>, <name><surname>Sidaoui</surname><given-names>M</given-names></name>, <name><surname>Schmarzo</surname><given-names>B</given-names></name>. <article-title>Convergence of artificial intelligence with social media: A bibliometric &#x00026; qualitative analysis</article-title>. <source>Telematics and Informatics Reports</source>. <year>2024</year>;<volume>14</volume>:<fpage>100146</fpage>.</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="webpage"><collab>IBM</collab>. <source>What is Artificial Intelligence (AI)?</source>
<year>2024</year> [Available from: <ext-link xlink:href="https://www.ibm.com/topics/artificial-intelligence" ext-link-type="uri">https://www.ibm.com/topics/artificial-intelligence</ext-link>.</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="webpage"><collab>U.S. Centers for Disease Control and Prevention</collab>. <source>Artificial Intelligence and Machine Learning</source> [updated <date-in-citation>July 3, 2023</date-in-citation>. Available from: <ext-link xlink:href="https://www.cdc.gov/surveillance/data-modernization/technologies/ai-ml.html" ext-link-type="uri">https://www.cdc.gov/surveillance/data-modernization/technologies/ai-ml.html</ext-link>.</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="webpage"><collab>IBM</collab>. <source>What is computer vision?</source> [Available from: <ext-link xlink:href="https://www.ibm.com/topics/computer-vision" ext-link-type="uri">https://www.ibm.com/topics/computer-vision</ext-link>.</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Piccialli</surname><given-names>F</given-names></name>, <name><surname>di Cola</surname><given-names>VS</given-names></name>, <name><surname>Giampaolo</surname><given-names>F</given-names></name>, <name><surname>Cuomo</surname><given-names>S</given-names></name>. <article-title>The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic</article-title>. <source>Inf Syst Front</source>. <year>2021</year>;<volume>23</volume>(<issue>6</issue>):<fpage>1467</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">33935585</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>D</given-names></name>, <name><surname>Tong</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <etal/>
<article-title>Artificial Intelligence for COVID-19: A Systematic Review</article-title>. <source>Front Med (Lausanne)</source>. <year>2021</year>;<volume>8</volume>:<fpage>704256</fpage>.<pub-id pub-id-type="pmid">34660623</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Kamitani</surname><given-names>E</given-names></name>, <name><surname>Mizuno</surname><given-names>Y</given-names></name>, <name><surname>Khalil</surname><given-names>GM</given-names></name>, <name><surname>Viguerie</surname><given-names>A</given-names></name>, <name><surname>DeLuca</surname><given-names>JB</given-names></name>, <name><surname>Mishra</surname><given-names>N</given-names></name>. <article-title>Improving HIV Pre-exposure Prophylaxis Uptake with Artificial Intelligence and Automation: A Systematic Review</article-title>. <source>AIDS (London, England)</source>. <year>2024</year>.</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="webpage"><name><surname>Kamitani</surname><given-names>E</given-names></name>, <name><surname>Mizuno</surname><given-names>Y</given-names></name>, <name><surname>Mishra</surname><given-names>N</given-names></name>, <name><surname>Khalil</surname><given-names>G</given-names></name>, <name><surname>Viguerie</surname><given-names>A</given-names></name>, <name><surname>DeLuca</surname><given-names>JB</given-names></name>. <article-title>Artificial Intelligence Used in Interventions or Programs to Promote HIV Pre-exposure Prophylaxis (PrEP) Clinical Care: A Systematic Review</article-title>. <source>PROSPERO [Internet]</source>. <year>2023</year>; <fpage>CRD42023458870</fpage>. Available from: <ext-link xlink:href="https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=458870" ext-link-type="uri">https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=458870</ext-link>.</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Page</surname><given-names>MJ</given-names></name>, <name><surname>McKenzie</surname><given-names>JE</given-names></name>, <name><surname>Bossuyt</surname><given-names>PM</given-names></name>, <name><surname>Boutron</surname><given-names>I</given-names></name>, <name><surname>Hoffmann</surname><given-names>TC</given-names></name>, <name><surname>Mulrow</surname><given-names>CD</given-names></name>, <etal/>
<article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>. <source>Bmj</source>. <year>2021</year>;<volume>372</volume>:<fpage>n71</fpage>.<pub-id pub-id-type="pmid">33782057</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="book"><name><surname>Munn</surname><given-names>Z</given-names></name>, <name><surname>Moola</surname><given-names>S</given-names></name>, <name><surname>Lisy</surname><given-names>K</given-names></name>, <name><surname>Riitano</surname><given-names>D</given-names></name>, <name><surname>Tufanaru</surname><given-names>C</given-names></name>. <part-title>Chapter 5: Systematic reviews of prevalence and incidence</part-title>. <year>2020</year> [cited <date-in-citation>January 19, 2024</date-in-citation>]. In: <source>JBI Manual for Evidence Synthesis [Internet]</source>. <publisher-name>JBI</publisher-name>, [cited <date-in-citation>January 19, 2024</date-in-citation>]. Available from: <ext-link xlink:href="https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fjbi.global%2Fsites%2Fdefault%2Ffiles%2F2021-10%2FChecklist_for_Prevalence_Studies.docx&#x00026;wdOrigin=BROWSELINK" ext-link-type="uri">https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fjbi.global%2Fsites%2Fdefault%2Ffiles%2F2021-10%2FChecklist_for_Prevalence_Studies.docx&#x00026;wdOrigin=BROWSELINK</ext-link>.</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Munn</surname><given-names>Z</given-names></name>, <name><surname>Moola</surname><given-names>S</given-names></name>, <name><surname>Lisy</surname><given-names>K</given-names></name>, <name><surname>Riitano</surname><given-names>D</given-names></name>, <name><surname>Tufanaru</surname><given-names>C</given-names></name>. <article-title>Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data</article-title>. <source>Int J Evid Based Healthc</source>. <year>2015</year>;<volume>13</volume>(<issue>3</issue>):<fpage>147</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">26317388</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>C</given-names></name>, <name><surname>Dasgupta</surname><given-names>P</given-names></name>, <name><surname>Cameron</surname><given-names>J</given-names></name>, <name><surname>Fritschi</surname><given-names>L</given-names></name>, <name><surname>Baade</surname><given-names>P</given-names></name>. <article-title>A systematic review and meta-analysis on international studies of prevalence, mortality and survival due to coal mine dust lung disease</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>(<issue>8</issue>):<fpage>e0255617</fpage>.<pub-id pub-id-type="pmid">34343220</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>van der Kruk</surname><given-names>S</given-names></name>, <name><surname>Harrison</surname><given-names>NJ</given-names></name>, <name><surname>Bartram</surname><given-names>A</given-names></name>, <name><surname>Newton</surname><given-names>S</given-names></name>, <name><surname>Miller</surname><given-names>C</given-names></name>, <name><surname>Room</surname><given-names>R</given-names></name>, <etal/>
<article-title>Prevalence of parental supply of alcohol to minors: a systematic review</article-title>. <source>Health Promotion International</source>. <year>2023</year>;<volume>38</volume>(<issue>5</issue>).</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Aonso-Diego</surname><given-names>G</given-names></name>, <name><surname>Krotter</surname><given-names>A</given-names></name>, <name><surname>Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>&#x000c1;</given-names></name>. <article-title>Prevalence of energy drink consumption world-wide: A systematic review and meta-analysis</article-title>. <source>Addiction</source>.n/a(n/a).</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Nobles</surname><given-names>AL</given-names></name>, <name><surname>Leas</surname><given-names>EC</given-names></name>, <name><surname>Noar</surname><given-names>S</given-names></name>, <name><surname>Dredze</surname><given-names>M</given-names></name>, <name><surname>Latkin</surname><given-names>CA</given-names></name>, <name><surname>Strathdee</surname><given-names>SA</given-names></name>, <etal/>
<article-title>Automated image analysis of instagram posts: Implications for risk perception and communication in public health using a case study of #HIV</article-title>. <source>PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>5</issue>):<fpage>e0231155</fpage>.<pub-id pub-id-type="pmid">32365124</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Nobles</surname><given-names>AL</given-names></name>, <name><surname>Leas</surname><given-names>EC</given-names></name>, <name><surname>Latkin</surname><given-names>CA</given-names></name>, <name><surname>Dredze</surname><given-names>M</given-names></name>, <name><surname>Strathdee</surname><given-names>SA</given-names></name>, <name><surname>Ayers</surname><given-names>JW</given-names></name>. <article-title>#HIV: Alignment of HIV-Related Visual Content on Instagram with Public Health Priorities in the US</article-title>. <source>AIDS Behav</source>. <year>2020</year>;<volume>24</volume>(<issue>7</issue>):<fpage>2045</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">31916098</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>Q</given-names></name>, <name><surname>McMann</surname><given-names>T</given-names></name>, <name><surname>Godinez</surname><given-names>H</given-names></name>, <name><surname>Nali</surname><given-names>MC</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Cai</surname><given-names>M</given-names></name>, <etal/>
<article-title>Impact of COVID-19 on HIV Prevention Access: A Multi-platform Social Media Infodemiology Study</article-title>. <source>AIDS Behav</source>. <year>2023</year>;<volume>27</volume>(<issue>6</issue>):<fpage>1886</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">36471205</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>Q</given-names></name>, <name><surname>Nali</surname><given-names>MC</given-names></name>, <name><surname>McMann</surname><given-names>T</given-names></name>, <name><surname>Godinez</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>He</surname><given-names>Y</given-names></name>, <etal/>
<article-title>Unsupervised Machine Learning to Detect and Characterize Barriers to Pre-exposure Prophylaxis Therapy: Multiplatform Social Media Study</article-title>. <source>JMIR Infodemiology</source>. <year>2022</year>;<volume>2</volume>(<issue>1</issue>):<fpage>e35446</fpage>.<pub-id pub-id-type="pmid">37113799</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Adrover</surname><given-names>C</given-names></name>, <name><surname>Bodnar</surname><given-names>T</given-names></name>, <name><surname>Huang</surname><given-names>Z</given-names></name>, <name><surname>Telenti</surname><given-names>A</given-names></name>, <name><surname>Salath&#x000e9;</surname><given-names>M</given-names></name>. <article-title>Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter</article-title>. <source>JMIR Public Health Surveill</source>. <year>2015</year>;<volume>1</volume>(<issue>2</issue>):<fpage>e7</fpage>.<pub-id pub-id-type="pmid">27227141</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Stevens</surname><given-names>R</given-names></name>, <name><surname>Bonett</surname><given-names>S</given-names></name>, <name><surname>Bannon</surname><given-names>J</given-names></name>, <name><surname>Chittamuru</surname><given-names>D</given-names></name>, <name><surname>Slaff</surname><given-names>B</given-names></name>, <name><surname>Browne</surname><given-names>SK</given-names></name>, <etal/>
<article-title>Association Between HIV-Related Tweets and HIV Incidence in the United States: Infodemiology Study</article-title>. <source>J Med Internet Res</source>. <year>2020</year>;<volume>22</volume>(<issue>6</issue>):<fpage>e17196</fpage>.<pub-id pub-id-type="pmid">32579119</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Klein</surname><given-names>AZ</given-names></name>, <name><surname>Meanley</surname><given-names>S</given-names></name>, <name><surname>O&#x02019;Connor</surname><given-names>K</given-names></name>, <name><surname>Bauermeister</surname><given-names>JA</given-names></name>, <name><surname>Gonzalez-Hernandez</surname><given-names>G</given-names></name>. <article-title>Toward Using Twitter for PrEP-Related Interventions: An Automated Natural Language Processing Pipeline for Identifying Gay or Bisexual Men in the United States</article-title>. <source>JMIR Public Health Surveill</source>. <year>2022</year>;<volume>8</volume>(<issue>4</issue>):<fpage>e32405</fpage>.<pub-id pub-id-type="pmid">35468092</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Erdengasileng</surname><given-names>A</given-names></name>, <name><surname>Tian</surname><given-names>S</given-names></name>, <name><surname>Green</surname><given-names>SS</given-names></name>, <name><surname>Naar</surname><given-names>S</given-names></name>, <name><surname>He</surname><given-names>Z</given-names></name>. <article-title>Using Twitter Data Analysis to Understand the Perceptions, Awareness, and Barriers to the Wide Use of Pre-Exposure Prophylaxis in the United States</article-title>. <source>Proceedings (IEEE Int Conf Bioinformatics Biomed)</source>. <year>2022</year>;<volume>2022</volume>:<fpage>3000</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">36818418</pub-id>
</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Adrover</surname><given-names>C</given-names></name>, <name><surname>Bodnar</surname><given-names>T</given-names></name>, <name><surname>Huang</surname><given-names>Z</given-names></name>, <name><surname>Telenti</surname><given-names>A</given-names></name>, <name><surname>Salathe</surname><given-names>M</given-names></name>. <article-title>Identifying adverse effects of HIV drug treatment and associated sentiments using Twitter</article-title>. <source>JMIR Public Health and Surveillance</source>. <year>2015</year>;<volume>1</volume>(<issue>2</issue>):<fpage>e7.1</fpage>&#x02013;<lpage>e7.10</lpage>.<pub-id pub-id-type="pmid">27227141</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="webpage"><collab>U.S. Food and Drug Administration</collab>. <source>Truvada for PrEP Fact Sheet: Ensuring Safe and Proper Use2012</source>
<month>October</month>
<day>28</day>, <year>2024</year> [cited <date-in-citation>2022 November 30th</date-in-citation>]. Available from: <ext-link xlink:href="https://www.fda.gov/media/83586/download" ext-link-type="uri">https://www.fda.gov/media/83586/download</ext-link>.</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Hong</surname><given-names>C</given-names></name>. <article-title>Characterizing the Impact of the COVID-19 Pandemic on HIV PrEP care: A Review and Synthesis of the Literature</article-title>. <source>AIDS Behav</source>. <year>2023</year>;<volume>27</volume>(<issue>7</issue>):<fpage>2089</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="pmid">36459263</pub-id>
</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="webpage"><collab>Gilead</collab>. <article-title>Medicaiton Guide: TRUVADA<sup>&#x000ae;</sup> (tru-VAH-dah) (emtricitabine and tenofovir disoproxil fumarate) tablets</article-title>. <source>What is TRUVADA<sup>&#x000ae;</sup>? [Internet]</source>. <month>May</month>
<day>9</day>, <year>2024</year>. Available from: <ext-link xlink:href="https://www.gilead.com/~/media/Files/pdfs/medicines/hiv/truvada/truvada_medication_guide.pdf" ext-link-type="uri">https://www.gilead.com/~/media/Files/pdfs/medicines/hiv/truvada/truvada_medication_guide.pdf</ext-link>.</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Bonacci</surname><given-names>RA</given-names></name>, <name><surname>Van Handel</surname><given-names>M</given-names></name>, <name><surname>Huggins</surname><given-names>R</given-names></name>, <name><surname>Inusah</surname><given-names>S</given-names></name>, <name><surname>Smith</surname><given-names>DK</given-names></name>. <article-title>Estimated Uncovered Costs For HIV Preexposure Prophylaxis In The US, 2018</article-title>. <source>Health Aff (Millwood)</source>. <year>2023</year>;<volume>42</volume>(<issue>4</issue>):<fpage>546</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">37011310</pub-id>
</mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Ayerdi</surname><given-names>O</given-names></name>, <name><surname>Puerta</surname><given-names>T</given-names></name>, <name><surname>Clavo</surname><given-names>P</given-names></name>, <name><surname>Vera</surname><given-names>M</given-names></name>, <name><surname>Ballesteros</surname><given-names>J</given-names></name>, <name><surname>Fuentes</surname><given-names>ME</given-names></name>, <etal/>
<article-title>Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users</article-title>. <source>Open Forum Infectious Diseases</source>. <year>2020</year>;<volume>7</volume>(<issue>11</issue>).</mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="webpage"><collab>SAS</collab>. <source>Riverside County relies on data integration and analytics from SAS to improve the health and well-being of vulnerable Californians</source> [Available from: <ext-link xlink:href="https://www.sas.com/en_us/customers/riverside-county.html" ext-link-type="uri">https://www.sas.com/en_us/customers/riverside-county.html</ext-link>.</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="webpage"><collab>SAS</collab>. <source>Big Data: What it is and Why it Matters</source> [Available from: <ext-link xlink:href="https://www.sas.com/en_us/insights/big-data/what-is-big-data.html" ext-link-type="uri">https://www.sas.com/en_us/insights/big-data/what-is-big-data.html</ext-link>.</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>L</given-names></name>, <name><surname>Pan</surname><given-names>S</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Vasilakos</surname><given-names>AV</given-names></name>. <article-title>Machine learning on big data: Opportunities and challenges</article-title>. <source>Neurocomputing</source>. <year>2017</year>;<volume>237</volume>:<fpage>350</fpage>&#x02013;<lpage>61</lpage>.</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <source>Infodemic</source> [Available from: <ext-link xlink:href="https://www.who.int/health-topics/infodemic#tab=tab_1" ext-link-type="uri">https://www.who.int/health-topics/infodemic#tab=tab_1</ext-link>.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1:</label><caption><p id="P42">Flow diagram of included studies</p></caption><graphic xlink:href="nihms-2076763-f0001" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1:</label><caption><p id="P43">Study characteristics of pre-exposure prophylaxis (PrEP) infodemiology studies using artificial intelligence (AI) published from 2012 to 2024 (N=8)</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">First author (publication year)</th><th align="left" valign="top" rowspan="1" colspan="1">Used Social Media and AI</th><th align="left" valign="top" rowspan="1" colspan="1">Study Objectives</th><th align="left" valign="top" rowspan="1" colspan="1">Characteristics of Social Media Posts</th><th align="left" valign="top" rowspan="1" colspan="1">Relevant Findings</th><th align="left" valign="top" rowspan="1" colspan="1">Risk of Bias<sup><xref rid="TFN2" ref-type="table-fn">1</xref></sup></th></tr></thead><tbody><tr><td colspan="6" align="left" valign="top" rowspan="1">
<italic toggle="yes">Language Contents (n=6)</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Erdengasileng (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">X<break/><break/>ML</td><td align="left" valign="top" rowspan="1" colspan="1">Understand the perceptions, awareness, and barriers to using PrEP</td><td align="left" valign="top" rowspan="1" colspan="1">3,700 tweets posted from January 2018 to December 2021<break/>1,200 tweets were randomly selected.</td><td align="left" valign="top" rowspan="1" colspan="1">PrEP issues often discussed in personal tweets include advocacy, risks/benefits, access, pricing, insurance coverage, legislation, stigma, health education, and prevention of HIV.</td><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Xu (2023)</td><td align="left" valign="top" rowspan="1" colspan="1">X, Reddit, Instagram<break/><break/>ML</td><td align="left" valign="top" rowspan="1" colspan="1">Identify and characterize key barriers associated with access to PrEP therapy during the COVID-19 pandemic</td><td align="left" valign="top" rowspan="1" colspan="1">267,689 posts between March 13, 2020 and December 11, 2020.<break/>317 posts discussing PrEP and/or HIV prevention practices and also mention COVID-19</td><td align="left" valign="top" rowspan="1" colspan="1">COVID-19 pandemic contributed to disruptions in HIV prevention services that may impact PrEP uptake and adherence and other HIV prevention services, particularly among ethnic, racial, and sexual minority populations.</td><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Xu (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">X, YouTube, Tumblr, Instagram, Reddit<break/><break/>ML</td><td align="left" valign="top" rowspan="1" colspan="1">Identify and characterize barriers associated with PrEP uptake and adherence.</td><td align="left" valign="top" rowspan="1" colspan="1">522,430 posts from October 13, 2020, to December 11, 2020.<break/>785 posts were identified that specifically related to barriers.,</td><td align="left" valign="top" rowspan="1" colspan="1">The main barriers included a lack of knowledge, access issues (e.g., lack of insurance coverage, no prescription, the impact of COVID-19 pandemic), and low adherence (e.g., side effects, social stigma)</td><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Adrover (2015)</td><td align="left" valign="top" rowspan="1" colspan="1">X<break/><break/>ML</td><td align="left" valign="top" rowspan="1" colspan="1">Examine if adverse effects of HIV drug treatment and associated sentiments can be identified using social media data</td><td align="left" valign="top" rowspan="1" colspan="1">39,988,306 tweets were posted between September 2010 to August 2013.<break/>1,642 described personal experiences with HIV drug treatment</td><td align="left" valign="top" rowspan="1" colspan="1">Concerns for adverse effects expressed in social media about specific HIV drugs or drug combinations, accurately capture well-recognized toxicities.</td><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stevens (2020)</td><td align="left" valign="top" rowspan="1" colspan="1">X<break/><break/>NLP</td><td align="left" valign="top" rowspan="1" colspan="1">Examine how Twitter activity among young (13-24 years) men is associated with the incidence of HIV infection in the U.S.</td><td align="left" valign="top" rowspan="1" colspan="1">15.1 million tweets between January 1, 2016, and December 31, 2016.<break/>2,517 were identified as potentially relevant to HIV risk and prevention tags.</td><td align="left" valign="top" rowspan="1" colspan="1">Every 100-tweet increase in HIV-specific tweets per capita from the noninstitutional account was associated with a decrease in HIV incidence in the following year&#x0201d;</td><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Klein (2022)</td><td align="left" valign="top" rowspan="1" colspan="1">X<break/><break/>NLP</td><td align="left" valign="top" rowspan="1" colspan="1">Develop an automated NLP pipeline to identify MSM in the U.S. and assess the extent to which they demographically represent MSM in the US with new HIV diagnoses</td><td align="left" valign="top" rowspan="1" colspan="1">More than 3 million tweets between September 2020 and January 2021.<break/>8,756 unique users with US state-level geolocations.</td><td align="left" valign="top" rowspan="1" colspan="1">Among the 8,756 users with US state-level geolocations, 5096 (58.2%) were in the 10 states with the highest numbers of new HIV diagnoses. Among the 6240 users with county-level geolocations, 4252 (68.1%) were in counties or states considered priority jurisdictions by the Ending the HIV Epidemic initiative</td><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">
<italic toggle="yes">Visual Contents (n=2)</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nobles (2020)</td><td align="left" valign="top" rowspan="1" colspan="1">Instagram<break/><break/>ML, specifically CNN</td><td align="left" valign="top" rowspan="1" colspan="1">Implications for risk perception and communication in public health</td><td align="left" valign="top" rowspan="1" colspan="1">26,766 posts from January 2017 through July 2018.<break/>10,036 posts containing #HIV with detectable human face</td><td align="left" valign="top" rowspan="1" colspan="1">Compared to demographic characteristics of people with new HIV diagnoses in the U.S. in 2017, faces posted on Instagram containing #HIV were more likely to be white (43% vs. 26%), older (35-39 years old) (47% vs. 11%), andfemale (41% vs. 19%), and less likely to be black (31% vs 44%), and Hispanic (13% vs 25%). The results were similar among the subset of #HIV posts mentioning PrEP.</td><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nobles (2020)</td><td align="left" valign="top" rowspan="1" colspan="1">Instagram<break/><break/>NLP</td><td align="left" valign="top" rowspan="1" colspan="1">Explore thematic concepts in the image using automated image recognition and topic modeling</td><td align="left" valign="top" rowspan="1" colspan="1">39,233 posts containing #HIV from January 2017 through July 2018<break/>26,766 of the posts were authored in English</td><td align="left" valign="top" rowspan="1" colspan="1">Most posts containing #HIV focused on awareness (28%), LGBTQ (24.5%) or living with HIV (17.9%). Less than one third cited specific HIV strategies including HIV testing (10.8%), treatment (10.3%), PrEP (6.2%), and condoms (4.1%).</td><td align="left" valign="top" rowspan="1" colspan="1">Moderate</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P44">CNN: convolutional neural networks; LGBTQ: lesbian, gay, bisexual, transgender, queer or questioning; ML: machine learning; MSM: men who have sex with men; NLP: natural language processing; PrEP: pre-exposure prophylaxis</p></fn><fn id="TFN2"><label>1</label><p id="P45">Risk of Bias was assessed by using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Prevalence Studies.</p></fn></table-wrap-foot></table-wrap></floats-group></article>